Treatment outcomes in recurrent versus de novo metastatic pancreatic adenocarcinoma: a real world study

BACKGROUND: A majority of patients undergoing curative intent surgery for pancreatic ductal adenocarcinoma (PDAC) will unfortunately develop recurrent disease. Treatment outcomes for patients with metastatic disease remain suboptimal. In this study, we evaluated clinical outcomes of patients with re...

Descripción completa

Detalles Bibliográficos
Autores principales: Miotke, Laura, Nevala-Plagemann, Christopher, Ying, Jian, Florou, Vaia, Haaland, Benjamin, Garrido-Laguna, Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554966/
https://www.ncbi.nlm.nih.gov/pubmed/36224524
http://dx.doi.org/10.1186/s12885-022-10130-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554966/
https://www.ncbi.nlm.nih.gov/pubmed/36224524
http://dx.doi.org/10.1186/s12885-022-10130-4

Ejemplares similares